Pills leaning against coins"While it is true that specialty claims account for the largest chunk of spend, there are processes and programs available today that can assist in insulating the plan from increasing spend over time," says Bradley Nelson.

Exorbitant drug prices continue to vex employees and employers. Legislators at the federal and state levels have thus far been unable to agree on any significant fixes to rein in high prices, leaving employers and their benefits partners looking for creative solutions to ease the pain.

Of course, if there were one single solution to curbing pharmacy costs, we'd see it spread like wildfire across the benefits industry. Instead, there are myriad tactics at play, some more impactful than others. Understanding the pros and cons of each, and whether they're a fit for a particular company, can be difficult.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Emily Payne

Emily Payne is director, content analytics for ALM's Business & Finance Markets and former managing editor for BenefitsPRO. A Wisconsin native, she has spent the past decade writing and editing for various athletic and fitness publications. She holds an English degree and Business certificate from the University of Wisconsin.